NEW YORK, Oct. 06, 2025 (GLOBE NEWSWIRE) -- LB Pharmaceuticals Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX) today announced…
First-in-human cases lay the foundation for the next frontier in robotic microsurgeryJACKSONVILLE, Fla., Oct. 06, 2025 (GLOBE NEWSWIRE) -- MMI…
DAYTONA BEACH, FLORIDA / ACCESS Newswire / October 6, 2025 / Arrow Clinical Trials, a physician-owned clinical research site based…
Biotech, pharma and finance leaders attend “Rethinking Risk – How AI Can Optimize Biotech Capital Allocation”IRVINE, Calif., Oct. 06, 2025…
JUPITER, Fla., Oct. 06, 2025 (GLOBE NEWSWIRE) -- Dyadic International, Inc., d/b/a Dyadic Applied BioSolutions (“Dyadic”, “we”, “us”, “our”, or…
Additional update: Results of ongoing investigator-initiated proof-of-concept trial in United Arab Emirates (UAE) demonstrate further reduction of total parenteral support…
ESTERO, FLORIDA / ACCESS Newswire / October 6, 2025 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), developer…
Improvement observed in MDS-UPDRS scores in first 9 participants enrolled; 90-day follow-up continuing in remaining participants Plasma exposures in patients…
SANTA ANA, Calif., Oct. 06, 2025 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (OTC: NKGN) (“NKGen” or the “Company”), a clinical-stage…
- Results published in Oxford Academic’s Military Medicine Journal - - After up to 18 months of follow-up patients were…